Similar articles

• Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.

  Weber W, Metzger U, Laffer U, Egeli R. Weber W, et al. Anticancer Res. 1991 Jan-Feb;11(1):365-8. Anticancer Res. 1991. PMID: 1902076 Clinical Trial.
• [Following curative resection of colorectal cancer, portal chemotherapy especially benefits non-transfused patients].

  Harder F, Laffer U, Berres M, Jäggi P, Metzger U. Harder F, et al. Chirurg. 1990 Apr;61(4):280-5. Chirurg. 1990. PMID: 2112083 Clinical Trial. German.
• [Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].

  Metzger U, Laffer U, Egeli R, Barras J, Martinoli S, Müller W, Arma S, Bär HU, Schweizer W, Aeberhard P, et al. Metzger U, et al. Helv Chir Acta. 1989 Dec;56(4):455-60. Helv Chir Acta. 1989. PMID: 2517282 Clinical Trial. German.
• Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.

  Gerard A, Pector JC, Bleiberg H. Gerard A, et al. Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2351-4. Gan To Kagaku Ryoho. 1988. PMID: 3137873 Review.
• [Surgical treatment of hepatic metastases of colorectal neoplasms].

  Landi E. Landi E. G Chir. 2004 Oct;25(10):317-23. G Chir. 2004. PMID: 15756953 Review. Italian. No abstract available.